Iovance Biotherapeutics
IOVA
IOVA
200 hedge funds and large institutions have $3.44B invested in Iovance Biotherapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 75 increasing their positions, 60 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
25% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 60
16% more funds holding
Funds holding: 173 → 200 (+27)
1.31% less ownership
Funds ownership: 99.69% → 98.38% (-1.3%)
Holders
200
Holding in Top 10
10
Calls
$62.1M
Puts
$9.22M
Top Buyers
| 1 | +$56M | |
| 2 | +$34.7M | |
| 3 | +$19.4M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$12M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.02M |
Top Sellers
| 1 | -$49.1M | |
| 2 | -$44.2M | |
| 3 | -$30.2M | |
| 4 |
BC
Broadfin Capital
New York
|
-$16.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$12M |